Minimization of potential hERG liability in histamine H3 receptor antagonists

被引：14
|
作者：
Black, L. A. [1 ]
Liu, H. [1 ]
Diaz, G. J. [1 ]
Fox, G. B. [1 ]
Browman, K. E. [1 ]
Wetter, J. [1 ]
Marsh, K. C. [1 ]
Miller, T. R. [1 ]
Esbenshade, T. A. [1 ]
Brioni, J. [1 ]
Cowart, M. D. [1 ]
机构：
[1] Abbott Labs, GPRD Neurosci Res, Abbott Pk, IL 60064 USA
来源：
INFLAMMATION RESEARCH | 2008年 / 57卷 / Suppl 1期
关键词：
Benzofuran; Dofetilide; hERG Channel; Selectivity Ratio; Cyanophenyl;
D O I：
10.1007/s00011-007-0622-2
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：S45 / S46
页数：2
相关论文
共 50 条
  • [21] Discovery of substituted benzyl tetrazoles as histamine H3 receptor antagonists
    Davenport, Adam J.
    Stimson, Christopher C.
    Corsi, Massimo
    Vaidya, Darshan
    Glenn, Edward
    Jones, Timothy D.
    Bailey, Sarah
    Gemkow, Mark J.
    Fritz, Ulrike
    Hallett, David J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 5165 - 5169
  • [22] Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists
    Nirogi, Ramakrishna
    Shinde, Anil
    Tiriveedhi, Vinaykumar
    Kota, Laxman
    Saraf, Sangram Keshari
    Badange, Rajesh Kumar
    Mohammed, Abdul Rasheed
    Subramanian, Ramkumar
    Muddana, Nageshwararao
    Bhyrapuneni, Gopinadh
    Abraham, Renny
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 108 : 655 - 662
  • [23] Recent advances in histamine H3 receptor antagonists/inverse agonists
    Lazewska, Dorota
    Kiec-Kononowicz, Katarzyna
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (09) : 1147 - 1169
  • [24] Non-imidazole heterocyclic histamine H3 receptor antagonists
    Chai, WY
    Breitenbucher, JG
    Kwok, A
    Li, XB
    Wong, V
    Carruthers, NI
    Lovenberg, TW
    Mazur, C
    Wilson, SJ
    Axe, FU
    Jones, TK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (10) : 1767 - 1770
  • [25] A nticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
    Sadek, Bassem
    Saad, Ali
    Schwed, Johannes Stephan
    Weizel, Lilia
    Walter, Miriam
    Stark, Holger
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3633 - 3651
  • [26] Conformational analysis for some nonclassical antagonists of histamine H3 receptor
    Borota, Ana
    Mracec, Maria
    Rad, Ramona
    Ostopovici, Liliana
    Mracec, Mircea
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 2007, 107 (08) : 1803 - 1813
  • [27] Novel H3 receptor antagonists.: Sulfonamide homologs of histamine
    Wolin, R
    Connolly, M
    Afonso, A
    Hey, JA
    She, H
    Rivelli, MA
    Willams, SM
    West, RE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (16) : 2157 - 2162
  • [28] DESIGN OF MULTITARGETING HISTAMINE H3 RECEPTOR ANTAGONISTS FOR NEURODEGENERATIVE DISEASES
    Hagenow, S.
    Stasiak, A.
    Bautista-Aguilera, O.
    Palomino-Antolin, A.
    Farre-Alins, V.
    Jimeno, M. L.
    Martinez, A. Romero
    Lopez-Munoz, F.
    Iriepa, I.
    Moraled, I.
    Soukop, O.
    Janockova, J.
    Ismaili, L.
    Kalinowsky, L.
    Proschak, E.
    Schwed, J. S.
    Chioua, M.
    Egea, J.
    Marco-Contelles, J.
    Joffrin, P. -J.
    Ramsay, R. R.
    Stark, H.
    INFLAMMATION RESEARCH, 2018, 67 : S13 - S13
  • [29] Fluorinated non-imidazole histamine H3 receptor antagonists
    Isensee, K.
    Amon, M.
    Galaparti, A.
    Ligneau, X.
    Camelin, J. -C.
    Capet, M.
    Schwartz, J. -C.
    Stark, H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2172 - 2175
  • [30] Amine-constrained pyridazinone histamine H3 receptor antagonists
    Sundar, Babu G.
    Bailey, Thomas
    Bacon, Edward
    Aimone, Lisa
    Huang, Zeqi
    Lyons, Jacquelyn
    Raddatz, Rita
    Hudkins, Robert
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) : 5543 - 5546
12345